Multinational pharma producers are based in rich nations and demand high prices, thus hampering supply of medicine to the developing world. Globally enforced patents serve to protect high prices. At the same time, few new medicines are being developed for the health problems that mostly affect poor countries. Today, even rich nations are increasingly complaining about the skyrocketing costs of new drugs which often do only little good.